Fingerprint
Dive into the research topics of 'Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma
David J. Inwards, P. A. Fishkin, B. R. LaPlant, M. T. Drake, P. J. Kurtin, D. A. Nikcevich, D. B. Wender, B. S. Lair, T. E. Witzig
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations